InvestorsHub Logo
Followers 107
Posts 3850
Boards Moderated 0
Alias Born 09/29/2011

Re: ORCA post# 524

Wednesday, 06/27/2018 1:03:17 PM

Wednesday, June 27, 2018 1:03:17 PM

Post# of 3699
Look at it another way, they have $10.5 million in cash, no debt and four to five other drugs in pipeline that are mostly substantially funded by govt institutions etc. And there's over 50 percent chance of approval in August. And if that fails, the drug will be approved with modifications because it's efficacy was tested on about 2400 subjects with cooperation and approval of FDA. So, right now, company is priced at ZERO. My take.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SAVA News